Date	Title	Category
14-Sep-2009	Caution Statement on “Possible Interaction between Clopidogrel and Proton Pump Inhibitors” required to be included in the product package insert for Clopidogrel Bil (42) dlm. BPFK/PPP/01/03 dated 14th Sept 2009	DCA letters
13-Oct-2009	Caution Statement on “Increased Risk for Opportunistic Infections such as Activation of Latent Viral Infections Including BK Virus-Associated Nephropathy” required to be included in the product package insert for Immunosuppressant Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009	DCA letters
22-Jul-2010	Caution Statement on "Boxed warning" must include Propylthiouracil with "Severe Liver Injury" Bil (55) dlm. BPFK/PPP/01/03 dated 22nd Jul 2010	DCA letters
23-Feb-2011	Briefing on 'Competition Act 2010' by the Ms Shila Dorai Raj, Director of the Interim Competition Commission, MDTCC	General News
15-Sep-2009	Advertisement on Products for nicotine replacement therapy with MAB Approval Bil (37) dlm KKM-55/205/001/02 Jld 5 dated 15th Sept 2009	MAB Letter
12-Nov-2009	8th List for BE Studies for Oral “Immediate Release” Generic Products Bil (46) dlm. BPFK/PPP/01/03 dated 30th October 2009	DCA letters
24-Mar-2016	44th PhAMA Annual General Meeting 2016

21 - 27 of 27 results